DULUTH, Ga., Jan. 19, 2026 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, today announced that the U.S. Food and Drug Administration (FDA) has approved VETMEDIN (pimobendan) ...
The FDA approved the first drug designed to delay congestive heart failure in dogs The medication targets dogs with early heart disease before symptoms develop Early treatment may improve lifespan and ...
Boehringer Ingelheim, a global leader in animal health, announced that the US Food and Drug Administration (FDA) has approved Vetmedin (pimobendan) chewable tablets and Vetmedin solution (pimobendan ...
The MarketWatch News Department was not involved in the creation of this content. -- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimobendan) from ...
Heart disease affects approximately 10 percent of dogs in their lifetime1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...